EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

SPONTANEOUS RETROPERITONEAL HEMATOMA; UNCOMMON COMPLICATION OF ANTICOAGULATION IN PATIENT WITH SARS-COV-2 PNEUMONIA: CASE REPORT

*Dr. Bhushan S. Wankhade, Dr. Zeyad Faoor Alrais, Dr. Maged Mohsen Kamel Beniamein, Dr. Gopala Arun Kumar Naidu, Dr. Mohamed Elias Jammalmudugu and Dr. Jyoti Mathew

ABSTRACT

Coronavirus disease 2019 is caused by SARS-CoV-2 is new emergent infection, declared global pandemic by world health organization. Thromboembolic manifestation or thromboembolic complication in COVID-19 patients has been well described in medical literature. Which mandates the use of therapeutic or prophylactic anticoagulation in critically ill COVID-19 patients. Enoxaparin is frequently used as agent of choice for anticoagulation in ICU because of several advantages over other anticoagulant. We report a case of spontaneous retroperitoneal hematoma in critically ill COVID-19 patient receiving therapeutic anticoagulation with Enoxaparin. Which was successfully managed with aggressive resuscitation and endovascular treatment. Spontaneous retroperitoneal hematoma (SRH) is rare complication of enoxaparin therapy. Early diagnosis and aggressive treatment are of paramount importance as SRH is associated with high mortality and morbidity rates. We suggest caution while using anticoagulation in COVID-19 patients.

Keywords: COVID-19, Anticoagulation, Spontaneous retroperitoneal hematoma, Enoxaparin.

[Full Text Article] [Download Certificate]